Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Porrot

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Nature Communications|February 14, 2023
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Cell Reports. Medicine|November 30, 2022
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodiesTimothée Bruel, Karl Stéfic, Yann Nguyen, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
Nature Medicine|March 24, 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesTimothée Bruel, Jérôme Hadjadj, Piet Maes, et al.
Iscience|January 7, 2026
Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort studyGuillaume Martin-Blondel, Paul Burgat, Valentin Leducq, et al.
Nature Communications|May 4, 2022
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screenAlice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher, et al.
Iscience|July 29, 2024
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, et al.
Ebiomedicine|October 22, 2021
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyBlandine Monel, Delphine Planas, Ludivine Grzelak, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Eclinicalmedicine|July 27, 2022
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort studyTimothée Bruel, Laurie Pinaud, Laura Tondeur, et al.
Biorxiv : the Preprint Server for Biology|November 23, 2022
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Nature Communications|February 14, 2023
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodiesDelphine Planas, Timothée Bruel, Isabelle Staropoli, et al.
Cell Reports. Medicine|November 30, 2022
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodiesTimothée Bruel, Karl Stéfic, Yann Nguyen, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
Nature Medicine|March 24, 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesTimothée Bruel, Jérôme Hadjadj, Piet Maes, et al.
Iscience|January 7, 2026
Viral clearance and escape during therapy of COVID-19 outpatients: A prospective cohort studyGuillaume Martin-Blondel, Paul Burgat, Valentin Leducq, et al.
Nature Communications|May 4, 2022
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screenAlice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher, et al.
Iscience|July 29, 2024
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, et al.
Ebiomedicine|October 22, 2021
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyBlandine Monel, Delphine Planas, Ludivine Grzelak, et al.
Pageof 6